A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of <italic style="font-style: italic">Xingpi Capsule </italic>（醒脾胶囊）

Hongjiao LI; Lingxiang LI; Yuan WANG; Zhishan GE; Yanke AI; Tianyi ZHAO; Xiaoying LYU; Liyun HE

doi:10.13288/j.11-2166/r.2022.18.010

您当前的位置：

首页 >

文章列表页 >

A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of Xingpi Capsule （醒脾胶囊）

更新时间：2022-09-14

- A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of Xingpi Capsule （醒脾胶囊）
- Journal of Traditional Chinese Medicine Vol. 63, Issue 18, Pages: 1753-1759(2022)
- 作者机构：
  
  1.中国中医科学院中医临床基础医学研究所，北京市东城区东直门内南小街16号，100700
  2.内蒙古民族大学附属医院
  3.陕西中医药大学针灸推拿学院
  4.天津中医药大学
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2022.18.010
  CLC：
- Received：30 January 2022，
  
  Revised：2022-05-31，
  
  Published：17 September 2022
- 稿件说明：
移动端阅览
李洪皎,李凌香,王渊等.醒脾胶囊临床适宜病症的横断面调查研究[J].中医杂志,2022,63(18):1753-1759.

LI Hongjiao,LI Lingxiang,WANG Yuan,et al.A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of Xingpi Capsule （醒脾胶囊）[J].Journal of Traditional Chinese Medicine,2022,63(18):1753-1759.
李洪皎,李凌香,王渊等.醒脾胶囊临床适宜病症的横断面调查研究[J].中医杂志,2022,63(18):1753-1759. DOI： 10.13288/j.11-2166/r.2022.18.010.

LI Hongjiao,LI Lingxiang,WANG Yuan,et al.A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of Xingpi Capsule （醒脾胶囊）[J].Journal of Traditional Chinese Medicine,2022,63(18):1753-1759. DOI： 10.13288/j.11-2166/r.2022.18.010.

摘要

目的

总结临床实践中醒脾胶囊治疗的病症、使用方法和安全性等情况，为临床合理用药和上市后再评价提供参考。

方法

采用横断面调查，围绕临床医师用药关注的重点问题设计问卷，包含醒脾胶囊治疗病症、服用剂量、服用时间、联合用药和服药后不良反应等内容，在醒脾胶囊临床应用的8个省及直辖市，抽取62家医院，每家医院调查2名医师，共计调查124名医师。通过问卷星收集问卷，并辅以质量控制人员进行数据质量核查和跟踪。

结果

发放问卷124份，回收有效问卷111份。100名医师（90.1%）根据医师临床使用经验认为患者服用醒脾胶囊有效，76.6%的医师应用醒脾胶囊治疗慢性肠炎，此外还用于治疗慢性胃炎（64.0%）、肠易激综合征（56.8%）、失眠（40.5%）、胃溃疡（39.6%）。中医与西医医师使用醒脾胶囊治疗病症基本相似，但中医师与西医师认为醒脾胶囊能明显改善的症状不完全相同，相比西医师，中医师更倾向于认为醒脾胶囊对头晕（

P＝

0.028）和心慌（

P＝

0.028）有改善作用。受调查医师在治疗慢性肠炎（

P＝

0.032）、肠易激综合征（

P＝

0.006）、溃疡性结肠炎（

P＝

0.042）时倾向于单独使用醒脾胶囊，仅在用于治疗慢性肠炎时服药次数推荐更倾向每日2次（

＝0.014）。中医师推荐治疗不同病症的服药次数和服药量差异无统计学意义（

＞0.05），92.8%医师表示未发现患者服药后不适，7.2%医师表示患者服用醒脾胶囊后有胃肠道反应、皮肤瘙痒和药疹。

结论

医师应用醒脾胶囊主要治疗慢性肠炎、慢性胃炎、肠易激综合征、失眠、胃溃疡等病症，中医师与西医师使用醒脾胶囊治疗病症基本相同。

Abstract

Objective

To summarize the applications， usage and safety of

Xingpi Capsule

（醒脾胶囊） in clinical practice， thereby providing reference for its rational use and post-marketing evaluation.

Methods

A cross-sectional survey was conducted， and questionnaires were designed involving the key issues that clinicians paid attention to when using

Xingpi Capsules

， involving treated diseases and symptoms， dosage， medication time， combined medication and adverse reactions. Sixty-two hospitals were sampled from 8 provinces and municipalities where

Xingpi Capsule

have been clinically used， and two physicians were selected in each hospital. Totally， 124 physicians were surveyed. Questionnaires were collected through

Wenjuanxing

software， and quality control personnel were set for data quality verification and tracking.

Results

The response rate of total 124 questionnaires was 91.7%， and there were 111 valid questionnaires. Totally， 100 physicians （90.1%） believed that

Xingpi Capsule

was effective （the judgement was based on the clinical experience of physicians）. Most physicians have used

Xingpi Capsule

to treat chronic enteritis （76.6%）， as well as chronic gastritis （64.0%）， irritable bowel Syndrome （56.8%）， insomnia （40.5%）， and gastric ulcer （39.6%）. Traditional Chinese medicine （TCM） and Western medicine physicians treated similar diseases with

Xingpi Capsule

， but were different for treating clinical symptoms， where TCM physicians were more inclined to believe that

Xingpi Capsule

can significantly improve dizziness （

= 0.028） and palpitation （

= 0.028）. Physicians were more inclined to use

Xingpi Capsule

alone when treating chronic enteritis （

= 0.032）， irritable bowel syndrome （

= 0.006）， and ulcerative colitis （

= 0.042）， and took

Xingpi Capsule

twice daily

only for the treatment of chronic enteritis （

= 0.014）. In addition， there was no significant difference in the frequency and dosage of

Xingpi Capsule

recommended by practitioners for the treatment of different diseases and symptoms （

＞0.05）. For safety issue， 92.8% of the physicians said that they did not find uncomfortable conditions of the patients after taking

Xingpi Capsule

， while 7.2% of the physicians claimed patients reaction including gastrointestinal tract reactions， pruritus and drug eruption.

Conclusion

Xingpi Capsule

is mainly used to treat chronic enteritis， chronic gastritis， irritable bowel syndrome， insomnia， and gastric ulcer， which is similar between different professional physicians.

关键词

Keywords

references

孙鑫，张俊华，王雯，等 . 制定中国中成药真实世界研究技术指导原则，促进中成药临床研究向决策证据转化［J］. 中国循证医学杂志， 2020 ， 20 （ 9 ）： 993 - 999 .

张霄潇 . 制约中成药产业高质量发展的因素分析及对策探讨［J］. 中国现代中药， 2021 ， 23 （ 6 ）： 964 - 968 .

廖星，郭武栋，曹庄，等 . 应用卫生技术评估开展中成药临床综合评价［J］. 中国中药杂志， 2020 ， 45 （ 16 ）： 3749 - 3758 .

冯佳佳，董子洵，史楠楠，等 . 制定/修订《中成药临床应用循证指南》的方法与程序［J］. 中国研究型医院， 2020 ， 7 （ 3 ）： 93 - 97 .

刘保延 . 真实世界的中医临床科研范式［J］. 中医杂志， 2013 ， 54 （ 6 ）： 451 - 455 .

彭晓霞，舒啸尘，谭婧，等 . 基于真实世界数据评价治疗结局的观察性研究设计技术规范［J］. 中国循证医学杂志， 2019 ， 19 （ 7 ）： 779 - 786 .

庞博，郑文科，张俊华，等 . 中医药真实世界研究的应用场景［J］. 世界中医药， 2019 ， 14 （ 12 ）： 3115 - 3118，3122 .

国家药品不良反应监测中心 . 药品不良反应术语使用指南［S］. 北京：国家药品不良反应监测中心， 2016 ： 29 .

张伯礼 . 中成药上市后临床再评价：循证与创新［J］. 中国中药杂志， 2011 ， 36 （ 20 ）： 2761 .

李博，高蕊，李睿，等 . 中成药上市后再评价临床试验政策法规及操作规范探讨［J］. 中国新药杂志， 2014 ， 23 （ 6 ）： 650 - 653，664 .

李洪皎，刘保延，温泽淮等 . 抗病毒口服液治疗成人感冒上市后再评价的设计思路与方法［J］. 中医杂志， 2018 ， 59 （ 5 ）： 386 - 389 .

乔佳慧，杨浦，董丽，等 . 真实世界研究方法在中成药上市后安全性评价中的应用［J］. 中国新药杂志， 2021 ， 30 （ 9 ）： 769 - 772 .

张晨，于明坤，唐金平，等 . 目标值法在中药上市后再评价中的应用［J］. 中国中药杂志， 2021 ， 46 （ 8 ）： 1999 - 2003 .

李春晓，凌霄，李学林，等 . 中成药上市后安全性综合评价研究探讨［J］. 中医杂志， 2020 ， 61 （ 12 ）： 1049 - 1053 .

邱瑞瑾，李敏，胡嘉元，等 . 中成药上市后临床安全性评价核心数据集的构建方法探索［J］. 世界科学技术-中医药现代化， 2018 ， 20 （ 10 ）： 1723 - 1728 .

陈薇，邢建民，费宇彤，等 . 中医研究中问卷调查法的问卷设计要点及注意事项［J］. 中医杂志， 2008 ， 49 （ 8 ）： 696 - 697，711 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advantages，Challenges，and Implementation Pathways of Natural Experiments in Evaluating the Efficacy of Traditional Chinese Medicine

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Identification and Control Strategies for Immortal Time Bias in Traditional Chinese Medicine Cohort Studies

Characteristics of Traditional Chinese Medicine Syndromes and Treatment Rules in Ulcerative Colitis Patients in Jiangsu Province：Based on Real-World Data

Related Author

LIU Rihe

LIU Tingxiu

LIU Kai

SUN Yuan

ZHANG Xiaohan

LIU Jianping

LIU Zhaolan

ZHOU Xianmei

Related Institution

Center for Evidence-Based Medicine，Beijing University of Chinese Medicine

Center for Evidence-Based Medicine，Hospital of Chengdu University of Traditional Chinese Medicine

Sichuan Provincial Center for Evidence-Based Chinese Medicine

Affiliated Hospital of Nanjing University of Chinese Medicine

Institute of Basic Research in clinical Medicine，China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

A Cross-sectional Study on Clinically Appropriate Diseases and Symptoms of Xingpi Capsule （醒脾胶囊）

DOI：10.13288/j.11-2166/r.2022.18.010

摘要

Abstract

关键词

Keywords

references